AIM
ARK Investment Management’s Prime Medicine PRME Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.74M | Sell |
2,322,669
-772,503
| -25% | -$1.91M | 0.04% | 104 |
|
|
2025
Q1 | $6.16M | Sell |
3,095,172
-2,055,061
| -40% | -$4.09M | 0.06% | 104 |
|
|
2024
Q4 | $15M | Sell |
5,150,233
-510,486
| -9% | -$1.49M | 0.13% | 77 |
|
|
2024
Q3 | $21.9M | Sell |
5,660,719
-466,054
| -8% | -$1.8M | 0.2% | 62 |
|
|
2024
Q2 | $31.5M | Buy |
6,126,773
+133,419
| +2% | +$686K | 0.28% | 54 |
|
|
2024
Q1 | $42M | Buy |
5,993,354
+2,855,084
| +91% | +$20M | 0.29% | 51 |
|
|
2023
Q4 | $27.8M | Buy |
3,138,270
+515,841
| +20% | +$4.57M | 0.16% | 68 |
|
|
2023
Q3 | $25M | Buy |
2,622,429
+173,230
| +7% | +$1.65M | 0.19% | 64 |
|
|
2023
Q2 | $35.9M | Buy |
2,449,199
+526,922
| +27% | +$7.72M | 0.24% | 51 |
|
|
2023
Q1 | $23.6M | Buy |
1,922,277
+282,293
| +17% | +$3.47M | 0.16% | 65 |
|
|
2022
Q4 | $30.5M | Buy |
+1,639,984
| New | +$30.5M | 0.26% | 52 |
|